Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
The high incidence of acute organ rejection following heart transplantation poses major problems for patients, clinicians, and the healthcare system. A major clinical challenge in this regard arises from the difficulty of accurately
and efficiently diagnosing when organ rejection occurs. In Canada, the current approach to diagnosing acute rejection requires taking small pieces of the endomyocardium (EMB), which is a highly invasive and costly procedure. An alternative approach, currently not available in Canada, is to use a blood-based biomarker test called AlloMap; however, this test is ineffective during the period immediately after a heart transplant, when most rejection events
occur.
Robert McMaster
Ji-Young Kim
Genetics
Life sciences
Elevate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.